Discover 1,565 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,565
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer,
Location: Montvale NJ, New York NY, Harrison NY, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT05657873
Phase2, Recruiting
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: Montvale NJ, New York NY, Harrison NY, Basking Ridge NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06484062
Phase1, Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
for
Multiple Myeloma, Hypogammaglobulinemia,
Location: Montvale NJ, New York NY, Harrison NY, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06976476
Phase2, Recruiting
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
for
Colorectal Cancer, Liver Metastases
Location: Montvale NJ, New York NY, Harrison NY, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06130280
Phase2, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Montvale NJ, New York NY, Long Island City NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors